DrugPatentWatch Database Preview

Recordati Rare Company Profile

« Back to Dashboard

What is the competitive landscape for RECORDATI RARE, and what generic alternatives to RECORDATI RARE drugs are available?

RECORDATI RARE has eight approved drugs.

There are three US patents protecting RECORDATI RARE drugs.

Summary for Recordati Rare

US Patents:	3
Tradenames:	9
Ingredients:	8
NDAs:	8

Drugs and US Patents for Recordati Rare

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Recordati Rare	TRANXENE SD	clorazepate dipotassium	TABLET;ORAL	017105-005	Approved Prior to Jan 1, 1982		DISCN	No	No
Recordati Rare	DESOXYN	methamphetamine hydrochloride	TABLET, EXTENDED RELEASE;ORAL	005378-004	Approved Prior to Jan 1, 1982		DISCN	No	No
Recordati Rare	TRANXENE	clorazepate dipotassium	CAPSULE;ORAL	017105-003	Approved Prior to Jan 1, 1982		DISCN	No	No

Expired US Patents for Recordati Rare

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Recordati Rare	TRANXENE	clorazepate dipotassium	CAPSULE;ORAL	017105-001	Approved Prior to Jan 1, 1982	RE28315
Recordati Rare	TRANXENE	clorazepate dipotassium	TABLET;ORAL	017105-006	Approved Prior to Jan 1, 1982	RE28315
Recordati Rare	TRANXENE	clorazepate dipotassium	TABLET;ORAL	017105-007	Approved Prior to Jan 1, 1982	RE28315

Paragraph IV (Patent) Challenges for RECORDATI RARE drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Injection	10 mg/mL, 2 mL vial		2010-10-01

International Patents for Recordati Rare Drugs

Country	Document Number	Estimated Expiration
Canada	2377453
Mexico	PA02003033
Canada	2361160

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Recordati Rare